logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Aditya Bardia

UCLA Jonsson Comprehensive Cancer Center
H指数:86
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer

来自12,827例转移性乳腺癌患者循环DNA中可操作的遗传景观和动态

Nature Communications
IF15.7
2026-09-220
OAAI
Ignaty Leshchiner; Arielle J. Medford; Justin Cha; Lesli A. Kiedrowski; Andrzej Niemierko; Jennifer C. Keenan; Charles S. Dai; Laura M. Spring; Beverly Moy; Seth A. Wander; Neelima Vidula; Steven J. Isakoff; Dejan Juric; Mendy Miller; Andrew A. Davis; Lorenzo Gerratana; Ami Shah; Ben H. Park; Adam Brufsky; Joyce O’Shaughnessy; Rebecca J. Nagy; Leif W. Ellisen; Massimo Cristofanilli; Aditya Bardia; Gad Getz
Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer: results from the TROPION-Breast01 China cohort

德妥帕单抗德鲁克替康与化疗在既往治疗的不可手术/转移性激素受体阳性、人表皮生长因子受体2阴性乳腺癌中的比较：TROPION-Breast01中国队列的结果

ESMO Open
IF8.3
2026-09-010
OAAI
Wang, S.; Zhang, Q.; Jiang, Z.; Tong, Z.; Li, W.; Wang, J.; Ouyang, Q.; Yao, T.; Wang, Y.; Sun, M.; Wang, X.; Wang, S.; Zang, A.; Zhang, Z.; Chen, W.; Wang, X.; Li, H.; Sheng, Y.; Zhang, B.; Liu, C.; Zhao, K.; Munegowda, M. A.; Bardia, A.; Xu, B.
TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10

TroFuse-011研究设计：sacituzumab tirumotecan联合或不联合pembrolizumab治疗PD-L1 CPS<10的晚期三阴性乳腺癌

Future Oncology
IF2.6
2026-07-310
OA
Hope S. Rugo; Peter Schmid; Javier Cortes; Toshimi Takano; Peter A. Fasching; Yeon Hee Park; Giampaolo Bianchini; Sandra Ximena Franco; Cynthia Villarreal-Garza; Olivier Tredan; Yongmei Yin; Romualdo Barroso-Sousa; Xuan Peng; Usha Malhotra; Karen Lisa Smith; Aditya Bardia
Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancer

基于21基因Oncotype DX®测试识别激素受体阳性、人表皮生长因子受体2阴性的乳腺癌患者中侵袭性产后乳腺癌的窗口期

npj Breast Cancer
IF7.6
2026-07-010
OA
Shiliang Zhang; Katelyn J. Queen; Niharika Duggirala; Eric Yang; Marla Lipsyc-Sharf; Jennifer Racz; John Bennett; Kaden Hong; Yashila Suresh; Charlotte Hamilton; Meghana Pitta; Nicole Chien; Emily La; Christy A. Russell; Aditya Bardia; Nimmi S. Kapoor
Activating a B cell immune response regresses immunologically cold tumours

激活B细胞免疫反应使免疫冷肿瘤消退

Nature Nanotechnology
IF34.9
2026-06-120
PRE
Heena Aggarwal; Nimish Gupta; Aniruddha Sengupta; Arindam Sarkar; Sanghamitra Mylavarapu; Ivan S. Pires; Tanmoy Saha; Binayak Sarkar; Ashish Kulkarni; Vinay S. Mahajan; Lipika Goyal; Aditya Bardia; Richard Fahrner; Ermanno Gherardi; Raghunath Mashelkar; Patrick Soon-Shiong; Hae Lin Jang; Shiladitya Sengupta
Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone-receptor-positive HER2-negative breast cancer: final overall survival analysis of the phase 3 TROPION-Breast01 study

Datopotamab deruxtecan与化疗在先前治疗的不可手术/转移性激素受体阳性HER2-negative乳腺癌中的比较: 3期TROPION-Breast01研究的最终总体生存分析

Annals of Oncology
IF65.4
2025-12-230
PRE
B. Pistilli; K. Jhaveri; S.-A. Im; S. Pernas; M. De Laurentiis; S. Wang; N.Martínez Jañez; G. Borges; D.W. Cescon; M. Hattori; Y.-S. Lu; E. Hamilton; J. Tsurutani; K. Kalinsky; P.E.Rubini Liedke; D. Carroll; S. Khan; H.S. Rugo; B. Xu; A. Bardia
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis

HR+/HER2−转移性乳腺癌中细胞周期蛋白依赖性激酶4/6抑制剂暴露后的循环基因组景观：一项回顾性多机构联盟分析

npj Breast Cancer
IF7.6
2025-08-160
OAAI
Letizia Pontolillo; Andrew A. Davis; Lorenzo Gerratana; Arielle J. Medford; Judy Wang; Eleonora Nicolo’; Katherine Clifton; Marko Velimirovic; Surbhi Warrior; Emily Podany; Eleni Andreopoulou; Mara Serena Serafini; Laura Munoz-Arcos; Elisabetta Molteni; Marla Lipsyc-Sharf; Caterina Gianni; Nadia Bayou; Charles S. Dai; Diana Giannarelli; Emilio Bria; Cynthia X. Ma; Aditya Bardia; Carolina Reduzzi; Massimo Cristofanilli
US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan

美国专家德尔菲共识：datopotamab deruxtecan治疗患者的口腔炎预防与管理

Supportive Care in Cancer
IF3
2025-08-050
OA
Hope Rugo; Aditya Bardia; Debora S. Bruno; Vinicius Ernani; Erika Hamilton; Rebecca Heist; Komal Jhaveri; Benjamin Levy; Aaron Lisberg; Joyce O’Shaughnessy; Jacob Sands; Alexander Spira; Sara Tolaney; Nathaniel S. Treister; Cecile Matthews; Melissa Johnson
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

NF1基因改变与CDK4/6抑制剂耐药在激素受体阳性转移性乳腺癌中的从临床到基础研究的转化分析

eBioMedicine
IF10.8
2025-06-270
PRE
Maxwell R. Lloyd; Rosario Chica-Parrado; Caroline M. Weipert; Todd C. Knepper; Emily L. Podany; Fabiana Napolitano; Dan Ye; Chang-Ching Lin; Yasuaki Uemoto; Jiemin Liao; Claire Wegrzyn; Christine M. Walko; Lianne Y. Ryan; Jennifer C. Keenan; Arielle J. Medford; Shiyuan A. Liu; Gerburg M. Wulf; Katherine K. Clifton; Cynthia X. Ma; Hyo S. Han; Nicole Zhang; Leif W. Ellisen; Aditya Bardia; Carlos L. Arteaga; Ariella B. Hanker; Seth A. Wander
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study

ASCENT研究中，体重指数与转移性三阴性乳腺癌患者中sacituzumab govitecan的安全性和有效性之间的关联

ESMO Open
IF8.3
2025-06-010
OA
L. García-Estévez; A. Bardia; H.S. Rugo; L.A. Carey; V.C. Diéras; S. Loibl; M. Piccart; L. Gianni; K. Kalinsky; J. O’Shaughnessy; S.A. Hurvitz; E. Harting; T. Valdez; S. Phan; C. Lai; J. Cortés
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium

乳腺癌管理中的争议与关键知识空白专家观点：第一届弥合乳腺癌知识空白研讨会的会议录

Clinical Breast Cancer
IF2.5
2025-04-080
PRE
Komal Jhaveri; Carey K. Anders; Aditya Bardia; Manali Bhave; A. Jo Chien; Ian Krop; Tiffany A. Traina; Yara Abdou; Reva Basho; Alison K. Conlin; Francisco J. Esteva; Kevin R. Fox; Vijayakrishna Gadi; Peter A. Kaufman; Anya Litvak; Cynthia X. Ma; Eleftherios P. Mamounas; Heather McArthur; Kelly McCann; Zahi Mitri; Rebecca Shatsky; Melinda Telli; Mylin A. Torres; Kevin Kalinsky
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer

转移性乳腺癌中种族差异、ctDNA谱、靶向治疗使用及结局

JAMA NETWORK OPEN
IF9.7
2025-02-261
OA
Podany, Emily L.; Foffano, Lorenzo; Gerratana, Lorenzo; Medford, Arielle J.; Clifton, Katherine; Tapiavala, Shaili; Velimirovic, Marko; Lipsyc-Sharf, Marla; Reduzzi, Carolina; Bubie, Adrian; Putur, Annika; Ademuyiwa, Foluso O.; Puglisi, Fabio; Gradishar, William J.; Ma, Cynthia X.; Bardia, Aditya; Cristofanilli, Massimo; Davis, Andrew A.
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)
NPJ BREAST CANCER
IF7.6
2025-01-070
OA
Spring, Laura M.; Scarpetti, Lauren; Medford, Arielle J.; Niemierko, Andrzej; Comander, Amy; Mulvey, Therese; Schnipper, Lowell; Isakoff, Steven J.; Moy, Beverly; Wander, Seth A.; Shin, Jennifer; Ephrem, Zanta; Laposta, Anneke R.; Denault, Elyssa; Abraham, Elizabeth; Calistro, Gayle; Kalashnikova, Ekaterina; Rodriguez, Angel; Liu, Minetta C.; Aleshin, Alexey; Peppercorn, Jeffrey; Ellisen, Leif W.; Bardia, Aditya

研究方向

暂未获取到该数据
L
Laura M. Spring
H 指数:36论文数:469被引数:6,843
L
Leif W. Ellisen
H 指数:66论文数:464被引数:2.4万
B
Beverly Moy
H 指数:57论文数:429被引数:1.3万
J
Javier Cortés
H 指数:113论文数:1,481被引数:6.8万
S
Sara A. Hurvitz
H 指数:76论文数:713被引数:3.1万
D
Dejan Juric
H 指数:59论文数:732被引数:2.0万
S
Steven J. Isakoff
H 指数:60论文数:449被引数:2.6万
H
Hope S. Rugo
H 指数:137论文数:1,617被引数:10.1万
S
Sara M. Tolaney
H 指数:83论文数:1,341被引数:3.6万
S
Seth A. Wander
H 指数:35论文数:342被引数:5,375